INS and obesity disorder: Besides inflammation, obesity-driven factors such as elevated levels of free fatty acids (FFA) in muscle and liver tissues can directly disrupt insulin signaling pathways, in a process called lipotoxicity (Ahmed et al., 2021; Filipović et al., 2021).